Interval-training in Type 2 Diabetics
1 other identifier
interventional
14
1 country
1
Brief Summary
Interval training is superior to continuous training for improving glycemic control, hereunder glycemic variability and -spikes. However, the underlying mechanisms and the clinical impact is at present unknown. The overall objective of this project is to determine the mechanisms underlying aeroic interval-training-induced reductions in glycemic variability and -spikes, and the impact on levels of systemic inflammation in type 2 diabetes patients. It is hypothesized that aerobic interval training reduces glycemic variability and -spikes more than continuous training due to larger improvements in both peripheral insulin sensitivity and the mass action effect of glucose. Moreover, it is hypothesized that these reductions in glycemic variability and -spikes also reduces systemic inflammation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes-mellitus-type-2
Started Nov 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
December 8, 2014
CompletedFirst Posted
Study publicly available on registry
December 19, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedApril 27, 2016
April 1, 2016
1.3 years
December 8, 2014
April 26, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glycemic control
Glycemic control incl. glycemic variability and -spikes, will be measured with continuous glucose monitoring over 24 hours during standardized dietary intake before and after each intervention.
Change from baseline at 14 days
Secondary Outcomes (2)
Urinary isoprostanes as a measure of systemic inflammation
Change from baseline at 14 days
Rate of dissappearance during a 2-step (pancreatic + hyperinsulinemic) hyperglycemic clamp, as a measure of glucose effectiveness + insulin sensitivity
Change from baseline at 14 days
Other Outcomes (1)
Resting energy expenditure and respiratory exchange rate
Change from baseline at 14 days
Study Arms (3)
Control
EXPERIMENTALControl intervention: Subjects will continue their life unaltered during the 14 days intervention period
Continuous walking
EXPERIMENTALTraining intervention: Subjects will perform continuous walking for one hour per day at every weekday during the 14 days intervention period
Interval Walking
EXPERIMENTALTraining intervention: Subjects will perform interval walking for one hour per day at every weekday during the 14 days intervention period. Interval walking will be performed as repeated cycles of three minutes of slow and hree minutes of fast walking during the entire training session
Interventions
Eligibility Criteria
You may qualify if:
- Type 2 diabetes mellitus
- BMI \>18 but \<40 kg/m2
You may not qualify if:
- Pregnancy
- Smoking
- Contraindication to increased levels of physical activity
- More than moderate levels of physical activity (\>90 min/week) of maximally moderate intensity
- Insulin dependence
- Thyroid, liver, lung, heart or kidney disease, with the need for treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Centre for Physical Activity Research, Rigshospitalet
Copenhagen, 2100, Denmark
Related Publications (3)
Karstoft K, Clark MA, Jakobsen I, Knudsen SH, van Hall G, Pedersen BK, Solomon TPJ. Glucose effectiveness, but not insulin sensitivity, is improved after short-term interval training in individuals with type 2 diabetes mellitus: a controlled, randomised, crossover trial. Diabetologia. 2017 Dec;60(12):2432-2442. doi: 10.1007/s00125-017-4406-0. Epub 2017 Aug 25.
PMID: 28842722DERIVEDKarstoft K, Brinklov CF, Thorsen IK, Nielsen JS, Ried-Larsen M. Resting Metabolic Rate Does Not Change in Response to Different Types of Training in Subjects with Type 2 Diabetes. Front Endocrinol (Lausanne). 2017 Jun 13;8:132. doi: 10.3389/fendo.2017.00132. eCollection 2017.
PMID: 28659869DERIVEDKarstoft K, Clark MA, Jakobsen I, Muller IA, Pedersen BK, Solomon TP, Ried-Larsen M. The effects of 2 weeks of interval vs continuous walking training on glycaemic control and whole-body oxidative stress in individuals with type 2 diabetes: a controlled, randomised, crossover trial. Diabetologia. 2017 Mar;60(3):508-517. doi: 10.1007/s00125-016-4170-6. Epub 2016 Dec 9.
PMID: 27942800DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristian Karstoft, MD, PhD
Rigshospitalet, The Centre for Physical Activity Research
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
December 8, 2014
First Posted
December 19, 2014
Study Start
November 1, 2014
Primary Completion
February 1, 2016
Study Completion
April 1, 2016
Last Updated
April 27, 2016
Record last verified: 2016-04